Skip to main content
OpenTrials

Clinical trial condition

Palmoplantar Pustulosis

Explore clinical trials studying Palmoplantar Pustulosis. Study availability and eligibility vary by location and protocol.

15 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Palmoplantar Pustulosis trial results

Recruiting

A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis

NCT07013201

Conditions
Palmoplantar Pustulosis, Psoriasis, Skin Diseases, +2 more
Locations
  • LEO Pharma Investigational Site Fountain Valley, California, United States
  • LEO Pharma Investigational Site Douglasville, Georgia, United States
  • LEO Pharma Investigational Site West Bloomfield, Michigan, United States
  • LEO Pharma Investigational Site Elmhurst, New York, United States
View all 38 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis

NCT07219420

Conditions
Aggressive Periodontitis, Mouth Diseases, Palmoplantar Pustulosis, +7 more
Locations
  • Ppp001 50754 Birmingham, Alabama, United States
  • Ppp001 50746 Coral Gables, Florida, United States
  • Ppp001 50757 Auburn Hills, Michigan, United States
  • Ppp001 50745 Columbus, Ohio, United States
View all 87 locations
View Trial Details
Recruiting

Picankibart in Palmoplantar Pustulosis

NCT07552454

Conditions
Palmoplantar Pustulosis, Psoriasis, Skin Diseases, +2 more
Locations
  • Department of Dermatology, Xijing Hospital, Fourth Military Medical University, No. 127 of West Changle Road, 710032, Xi'an, Shaanxi, China Xi'an, Shaanxi, China
View Trial Details
Completed

A Registry Study of Palmoplantar Pustulosis (PPP) Treatment Patterns, Disease Burden and Treatment Outcomes in Japan

NCT04459507

Conditions
Palmoplantar Pustulosis, Psoriasis, Skin Diseases, +2 more
Locations
  • Akita University Hospital Akita, Japan
  • Juntendo University Hospital Bunkyō City, Japan
  • Kyushu University Hospital Fukuoka, Japan
  • Fukushima Medical University Hospital Fukushima, Japan
View all 39 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in Adults With Palmoplantar Pustulosis

NCT03633396

Conditions
Palmoplantar Pustulosis, Psoriasis, Skin Diseases, +2 more
Locations
  • Investigational Site Birmingham, Alabama, United States
  • Investigational Site Phoenix, Arizona, United States
  • Investigational Site Encino, California, United States
  • Investigational Site Santa Monica, California, United States
View all 39 locations
View Trial Details
Completed

Phase 3, Randomized Study of Apremilast in Japanese Participants With Palmoplantar Pustulosis (PPP)

NCT05174065

Conditions
Palmoplantar Pustulosis, Psoriasis, Skin Diseases, +2 more
Locations
  • Aichi Medical University Hospital Nagakute-shi, Aichi-ken, Japan
  • Nagoya City University Hospital Nagoya, Aichi-ken, Japan
  • Toho University Sakura Medical Center Sakura-shi, Chiba, Japan
  • Ehime University Hospital Toon-shi, Ehime, Japan
View all 40 locations
View Trial Details
Completed

Safety and Pharmacokinetics of Repeat Doses of CSL324 in Subjects With Hidradenitis Suppurativa and Palmoplantar Pustulosis

NCT03972280

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +11 more
Locations
  • Holdsworth House Medical Practice Darlinghurst, Australia
  • Fremantle Dermatology Fremantle, Australia
  • The Royal Melbourne Hospital Parkville, Australia
  • Westmead Hospital Westmead, Australia
View Trial Details

Related conditions